$11.7 Bn Genome Editing/Genome Engineering Markets - Global Analysis & Forecasts to 2026
December 20, 2021 05:28 ET
|
Research and Markets
Dublin, Dec. 20, 2021 (GLOBE NEWSWIRE) -- The "Genome Editing/Genome Engineering Market - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The global genome...
Global RNA Targeting Small Molecules Therapeutics Market Research Report 2021 with Analysis & Forecasts to 2030
November 09, 2021 06:18 ET
|
Research and Markets
Dublin, Nov. 09, 2021 (GLOBE NEWSWIRE) -- The "RNA Targeting Small Molecules Therapeutics Market by Type of Target Molecule, Type of Approach, Target Indication, Target Therapeutic Area, Route of...
Antisense Oligonucleotide Therapeutics Pipeline Insight Report 2021: Focus on 15+ Companies and 15+ Pipeline Drugs
October 18, 2021 11:23 ET
|
Research and Markets
Dublin, Oct. 18, 2021 (GLOBE NEWSWIRE) -- The "Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com's offering. This "Antisense...
Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference
September 21, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will participate in the 11th annual Partnership...
Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity’s Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies
April 06, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, April 06, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing...
Antisense Therapeutics to Present at Rodman & Renshaw 11th Annual Healthcare Conference
August 31, 2009 10:39 ET
|
Antisense
MELBOURNE, AUSTRALIA--(Marketwire - August 31, 2009) - Antisense Therapeutics Limited
(PINKSHEETS: ATHJY) (ASX: ANP) today announced that the Company is
scheduled to present at the Rodman &...